Mortgage Blog
RI treasurer issues RFP for top state financial advisor
The Public Resources Advisory Group, based in New York City, has held the contract since 2015.
Lab Notes: Arbutus begins human testing of potential hepatitis B cure
A roundup of recent Philadelphia-area life sciences news, including medical device makers Strados Labs and Helius Medical enter into product deals.
The Same House announces grant to the John R. Lewis Legacy Institute
The Same House’s grant to the John Lewis Legacy Institute will also help support initiatives tied to food insecurity and cancer awareness.
Pharmacare Hawaii focuses on health care services
“My grandfather opened [Yoshino Drug Store at the corner of King and Kaheka streets] in 1929. My father then ran [the business] in 1959, and my partner [Rick Sakurada] and I established Pharmacare Hawaii in 1983,.” said Byron Yoshino, who is the company’s current president and CEO.
Incyte shares decline on FDA rejection for updated Jakafi tablet
Incyte's Jakafi drug generated $2.4 billion, or 88% of the company's total revenue in 2022.
SVB execs’ pay soared on risks that eventually sank bank
The pay of SVB Financial Group CEO Greg Becker and Chief Financial Daniel Beck soared between 2017 and 2021 because of investments they oversaw that produced big returns in those years but eventually helped to sink Silicon Valley Bank, according to a Financial Times report. Click through to read more, including why “clowback” provisions in those compensation agreements may not apply in this case.
Here are Georgia’s top financial advisors, according to Barron’s
Meet Georgia's top financial advisors, according to Barron's annual list.
Ally hires Goldman Sachs exec Russell Hutchinson as new CFO, to be based in Charlotte
Ally Financial is shaking up its C-suite with the addition of a new CFO from Goldman Sachs.
Merill Pittsburgh loses top executive to Denver
Gabrielle Hodgson, Merrill's western Pennsylvania market executive since 2021, now leading the investment services giant's Denver market.
Why Silicon Valley Bank’s collapse could be bad for startups, good for venture capitalists
Ripple effects from the demise of Silicon Valley Bank continue to reverberate through the U.S. startup ecosystem. The collapse could hamper companies' abilities to raise funds and means there “is going to be less capital available, and probably very little debt capital available to startups,” said Vic Gatto, general managing partner of Nashville-based Jumpstart Capital. But conversely, it's “a really attractive time to invest” for venture capitalists, he added. Click through to read why.